Abstract:Abstract Background Mesenchymal stromal cells (MSCs) constitute one of the cell types most frequently used in cell therapy. Although several studies have shown the efficacy of these cells to modulate inflammation in different animal models, the results obtained in human clinical trials have been more modest. Here, we aimed at improving the therapeutic properties of MSCs by inducing a transient expression of two molecules that could enhance two different properties of these cells. With the purpose of improving MSC migration towards inflamed sites, we induced a transient expression of the C-X-C chemokine receptor type 4 (CXCR4). Additionally, to augment the anti-inflammatory properties of MSCs, a transient expression of the anti-inflammatory cytokine, interleukin 10 (IL10), was also induced. Methods Human adipose tissue-derived MSCs were transfected with messenger RNAs carrying the codon-optimized versions of CXCR4 and/or IL10. mRNA-transfected MSCs were then studied, first to evaluate whether the characteristic phenotype of MSCs was modified. Additionally, in vitro and also in vivo studies in an LPS-induced inflamed pad model were conducted to evaluate the impact associated to the transient expression of CXCR4 and/or IL10 in MSCs. Results Transfection of MSCs with CXCR4 and/or IL10 mRNAs induced a transient expression of these molecules without modifying the characteristic phenotype of MSCs. In vitro studies then revealed that the ectopic expression of CXCR4 significantly enhanced the migration of MSCs towards SDF-1, while an increased immunosuppression was associated with the ectopic expression of IL10. Finally, in vivo experiments showed that the co-expression of CXCR4 and IL10 increased the homing of MSCs into inflamed pads and induced an enhanced anti-inflammatory effect, compared to wild-type MSCs. Conclusions Our results demonstrate that the transient co-expression of CXCR4 and IL10 enhances the therapeutic potential of MSCs in a local inflammation mouse model, suggesting that these mRNA-modified cells may constitute a new step in the development of more efficient cell therapies for the treatment of inflammatory diseases.

Overexpression of COX-2 but Not Indoleamine 2,3-Dioxygenase-1 Enhances the Immunosuppressive Ability of Human Umbilical Cord-Derived Mesenchymal Stem Cells

Mtor Inhibition Improves the Immunomodulatory Properties of Human Bone Marrow Mesenchymal Stem Cells by Inducing COX-2 and PGE(2)

Mesenchymal Stem Cells: a Double-Edged Sword in Regulating Immune Responses

IFN-γ Can Promote the Immunosuppressive Capacity of Human Umbilical Cord Mesenchymal Stem Cells by Expression of Indoleamine 2,3-Dioxygenase

Human Umbilical Cord Mesenchymal Stem Cells Huc-Mscs Exert Immunosuppressive Activities Through a PGE2-dependent Mechanism.

Preconditioning with interleukin‐1 beta and interferon‐gamma enhances the efficacy of human umbilical cord blood‐derived mesenchymal stem cells‐based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3‐dioxygenase activity in dextran sulfate sodium‐induced colitis

Enhancement of Immunoregulatory Function of Modified Bone Marrow Mesenchymal Stem Cells by Targeting SOCS1.

[Ifn-Γ Stimulation Enhances Immunosuppressive Capability of Human Umbilical Cord Mesenchymal Stem Cells].

Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression

The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells

Soluble molecules are key in maintaining the immunomodulatory activity of murine mesenchymal stromal cells.

A CD8 T Cell/indoleamine 2,3-Dioxygenase Axis is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus.

MCP-1 Priming Enhanced the Therapeutic Effects of Human Mesenchymal Stromal Cells on Contact Hypersensitivity Mice by Activating the COX2-PGE2/STAT3 Pathway.

Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis

Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs

TGF-β Promotes Immune Responses in the Presence of Mesenchymal Stem Cells

Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10

CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells.

Inflammatory Cytokine Induced Immunosuppression in Mesenchymal Stem Cells

SOD2 promotes the immunosuppressive function of mesenchymal stem cells at the expense of adipocyte differentiation

Supplementary Figures 1 - 7 from Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment